Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Immutep Ltd ADR (IMMP)

Immutep Ltd ADR (IMMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Immutep Ltd ADR LEVEL 32 SUITE 32.07 AUSTRALIA SQUARE 264 GEORGE STREET SYDNEY C3 2000 AUS

www.immutep.com Employees: 51 P: 61-2-8315-7003 F: +61 285691880

Sector:

Medical

Description:

Immutep Limited is a biotechnology company. It engaged in developing novel immunotherapy treatments for cancer and autoimmune disease. The company's product pipeline consists of eftilagimod alpha, IMP731, IMP701 and IMP761 which are in clinical stage. It operates primarily in Europe, Australia and the U.S. Immutep Limited, formerly known as Prima BioMed Ltd, is headquartered in Sydney, Australia.

Key Statistics

Overview:

Market Capitalization, $K 431,800
Enterprise Value, $K 388,870
Shares Outstanding, K 147,372
Annual Sales, $ 6,690 K
Annual Net Income, $ -39,780 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,075 K
EBIT, $ 0 K
EBITDA, $ -37,150 K
60-Month Beta 1.92
% of Insider Shareholders 3.07%
% of Institutional Shareholders 2.32%
Float, K 142,848
% Float 96.93%
Short Interest 4,858
Short Float 3.30%
Short Volume Ratio 0.43

Growth:

1-Year Return 35.58%
3-Year Return 47.98%
5-Year Return -11.21%
5-Year Revenue Growth -39.62%
5-Year Earnings Growth -22.73%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 01/01/70
Earnings Per Share ttm 0.00
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 3-10 on 12/28/16

IMMP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -594.62%
Debt/Equity 0.01
Price/Sales 66.30
Price/Cash Flow N/A
Price/Book 4.75
Book Value/Share 0.63
Interest Coverage -6.08
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar